The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case–control study

No abstract is available for this paper.

• Publication year

  2018

• Venue

  BJOG: an International Journal of Obstetrics and Gynaecology

• Publication date

  2018-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1471-0528.15151PMID 29412502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormonal and reproductive factors and the risk of ovarian cancer

  2017cited by this paper
• Current Therapies for the Medical Management of Diabetes.

  2016cited by this paper
• A package for statistical analysis in epidemiology

  2016cited by this paper
• Effect of Lipophilic and Hydrophilic Statins on Breast Cancer Risk in Thai Women: A Cross-sectional Study

  2016cited by this paper
• Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.

  2016cited by this paper
• Statistical Models In Epidemiology

  2016cited by this paper
• Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies

  2015cited by this paper
• Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus

  2015cited by this paper
• The association between overweight, obesity and ovarian cancer: a meta-analysis.

  2015cited by this paper
• Metformin and epithelial ovarian cancer therapeutics

  2015cited by this paper
• Statin use and risk for ovarian cancer: a Danish nationwide case–control study

  2014cited by this paper
• Metformin and Cancer: Mounting Evidence Against an Association

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Use of Health Registers

  2014cited by this paper
• Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.

  2014cited by this paper
• The effect of statins on risk and survival of gynecological malignancies.

  2013cited by this paper
• Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based study

  2013cited by this paper
• The Effects of Metformin on Ovarian Cancer: A Systematic Review

  2013cited by this paper
• Cancer occurrence in Danish diabetic patients: duration and insulin effects

  2012cited by this paper
• Ovarian cancer: etiology, risk factors, and epidemiology.

  2012cited by this paper
• Metformin and neoplasia: implications and indications.

  2012cited by this paper
• Use of metformin and the risk of ovarian cancer: a case-control analysis.

  2011cited by this paper
• Lexis: An R Class for Epidemiological Studies with Long-Term Follow-Up

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Evaluation of case inclusion in two population-based diabetes registers

  2010cited by this paper
• Statin use and female reproductive organ cancer risk in a large population-based setting

  2009cited by this paper
• New Users of Metformin Are at Low Risk of Incident Cancer

  2009cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  2008cited by this paper
• Do the cholesterol-lowering properties of statins affect cancer risk?

  2008cited by this paper
• Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

  2007cited by this paper
• High concordance between self-reported medication and official prescription database information

  2007cited by this paper
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

  2007cited by this paper
• Metformin and reduced risk of cancer in diabetic patients

  2005cited by this paper
• The statins as anticancer agents.

  2003cited by this paper
• Diabetes mellitus and ovarian cancer (Sweden)

  2002cited by this paper
• Case-control studies.

  1995cited by this paper
• Data quality and quality control of a population-based cancer registry. Experience in Finland.

  1994cited by this paper

• Statins and the risk of gynecological cancer: a Norwegian population-based cohort study

  2025cites this paper
• Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study

  2024cites this paper
• Statins as Repurposed Drugs in Gynecological Cancer: A Review

  2022cites this paper
• Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer

  2022cites this paper
• Perspectives of metformin use in endometrial cancer and other gynaecological malignancies

  2021cites this paper
• The Causal Relationship between Type 2 Diabetes Mellitus and Ovarian Cancer: Two-Sample Mendelian Randomization

  2021cites this paper
• Statins as adjuvants in the treatment of ovarian cancer: controversy and misunderstanding.

  2021cites this paper
• Association between statin use and the risk, prognosis of gynecologic cancer: A meta-analysis.

  2021cites this paper
• Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women

  2020cites this paper
• Adaptation of metabolism to multicellular aggregation, hypoxia and obese stromal cell incorporation as potential measure of survival of ovarian metastases.

  2020cites this paper
• Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer

  2020cites this paper
• FinDM database on diabetes in Finland

  2020cites this paper
• Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).

  2020cites this paper
• Wise Management of Ovarian Cancer: On the Cutting Edge

  2020cites this paper
• Metformin and ovarian cancer: the evidence

  2020cites this paper
• Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis.

  2020cites this paper
• Recycling the Purpose of Old Drugs to Treat Ovarian Cancer

  2020cites this paper
• Do statins play any role in reducing the incidence and mortality of ovarian cancer? A systematic review and meta-analysis

  2020influential citation
• Exploring the Tumor and Premetastatic Microenvironment of the Ovary

  2019cites this paper
• The role of metformin and statins in ovarian and breast cancer in women with type 2 diabetes

  2019cites this paper
• Metformin Abrogates Age-Associated Ovarian Fibrosis

  2019cites this paper
• ’ s response to reviews Title : Statin use and the risk of ovarian and endometrial cancers : A meta-analysis

  2019cites this paper
• Statin use and the risk of ovarian and endometrial cancers: a meta-analysis

  2019cites this paper
• Association of metformin use with ovarian cancer incidence and prognosis: a systematic review and meta-analysis

  2019cites this paper
• Effect of metformin use on the risk and prognosis of ovarian cancer: an updated systematic review and meta-analysis.

  2019cites this paper
• The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.

  2019cites this paper
• ROLE OF SIMVASTATIN IN ADDITION TO METFORMIN IN POLYCYSTIC OVARIAN SYNDROME PATIENTS, A RANDOMIZED CONTROLLED TRIAL ON PAKISTANI WOMEN

  2018cites this paper